Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”

Detalles Bibliográficos
Autores principales: Casiraghi, Antonella, Gennari, Chiara Grazia, Musazzi, Umberto Maria, Ortenzi, Marco Aldo, Bordignon, Susanna, Minghetti, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560149/
https://www.ncbi.nlm.nih.gov/pubmed/32872340
http://dx.doi.org/10.3390/pharmaceutics12090822
_version_ 1783595022715715584
author Casiraghi, Antonella
Gennari, Chiara Grazia
Musazzi, Umberto Maria
Ortenzi, Marco Aldo
Bordignon, Susanna
Minghetti, Paola
author_facet Casiraghi, Antonella
Gennari, Chiara Grazia
Musazzi, Umberto Maria
Ortenzi, Marco Aldo
Bordignon, Susanna
Minghetti, Paola
author_sort Casiraghi, Antonella
collection PubMed
description
format Online
Article
Text
id pubmed-7560149
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75601492020-10-22 Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211” Casiraghi, Antonella Gennari, Chiara Grazia Musazzi, Umberto Maria Ortenzi, Marco Aldo Bordignon, Susanna Minghetti, Paola Pharmaceutics Reply MDPI 2020-08-28 /pmc/articles/PMC7560149/ /pubmed/32872340 http://dx.doi.org/10.3390/pharmaceutics12090822 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Casiraghi, Antonella
Gennari, Chiara Grazia
Musazzi, Umberto Maria
Ortenzi, Marco Aldo
Bordignon, Susanna
Minghetti, Paola
Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
title Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
title_full Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
title_fullStr Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
title_full_unstemmed Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
title_short Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
title_sort reply to “comment on casiraghi et al. ‘mucoadhesive budesonide formulation for the treatment of eosinophilic esophagitis’ 2020, 12, 211”
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560149/
https://www.ncbi.nlm.nih.gov/pubmed/32872340
http://dx.doi.org/10.3390/pharmaceutics12090822
work_keys_str_mv AT casiraghiantonella replytocommentoncasiraghietalmucoadhesivebudesonideformulationforthetreatmentofeosinophilicesophagitis202012211
AT gennarichiaragrazia replytocommentoncasiraghietalmucoadhesivebudesonideformulationforthetreatmentofeosinophilicesophagitis202012211
AT musazziumbertomaria replytocommentoncasiraghietalmucoadhesivebudesonideformulationforthetreatmentofeosinophilicesophagitis202012211
AT ortenzimarcoaldo replytocommentoncasiraghietalmucoadhesivebudesonideformulationforthetreatmentofeosinophilicesophagitis202012211
AT bordignonsusanna replytocommentoncasiraghietalmucoadhesivebudesonideformulationforthetreatmentofeosinophilicesophagitis202012211
AT minghettipaola replytocommentoncasiraghietalmucoadhesivebudesonideformulationforthetreatmentofeosinophilicesophagitis202012211

Ejemplares similares